Ira Goodman, MD

mild cognitive impairment
mild cognitive impairment
01/19/2015
Ira Goodman, MD; Nima Khosravani, MS; Kurt Cicillioni, BS; Anamaria Shanley, MSN, ARNP-BC
This article reviews the prevalence, cost, and diagnosis of AD and presents 2 case studies demonstrating the clinical utility of florbetapir, an amyloid imaging compound, as part of the diagnostic...
01/19/2015
mild cognitive impairment
mild cognitive impairment
01/19/2015
Ira Goodman, MD; Nima Khosravani, MS; Kurt Cicillioni, BS; Anamaria Shanley, MSN, ARNP-BC
This article reviews the prevalence, cost, and diagnosis of AD and presents 2 case studies demonstrating the clinical utility of florbetapir, an amyloid imaging compound, as part of the diagnostic...
01/19/2015
mild cognitive impairment
mild cognitive impairment
01/19/2015
Ira Goodman, MD; Nima Khosravani, MS; Kurt Cicillioni, BS; Anamaria Shanley, MSN, ARNP-BC
This article reviews the prevalence, cost, and diagnosis of AD and presents 2 case studies demonstrating the clinical utility of florbetapir, an amyloid imaging compound, as part of the diagnostic...
01/19/2015
mild cognitive impairment
mild cognitive impairment
01/19/2015
Ira Goodman, MD; Nima Khosravani, MS; Kurt Cicillioni, BS; Anamaria Shanley, MSN, ARNP-BC
This article reviews the prevalence, cost, and diagnosis of AD and presents 2 case studies demonstrating the clinical utility of florbetapir, an amyloid imaging compound, as part of the diagnostic...
01/19/2015